2013
DOI: 10.7314/apjcp.2013.14.6.3479
|View full text |Cite
|
Sign up to set email alerts
|

MCM3 as a Novel Diagnostic Marker in Benign and Malignant Salivary Gland Tumors

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

5
35
0

Year Published

2014
2014
2023
2023

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 39 publications
(50 citation statements)
references
References 21 publications
5
35
0
Order By: Relevance
“…Recently, a study has shown an expression of MCM3, a proliferation marker in SGT by immunohistochemical analysis with 74.3% sensitivity and 93.3% specificity between malignant and benign SGT. 31 A recent study on the expression of SPAG9 has predicted presence of malignant endometrium with 74% sensitivity, 83% specificity, 88% PPV, and 64.5% NPV. 32 In our study, SPAG9 protein expression in IHC predicted presence of malignant SGT with 83.72% sensitivity, 100% specificity, 100% PPV, and 83.72% NPV.…”
Section: Discussionmentioning
confidence: 99%
“…Recently, a study has shown an expression of MCM3, a proliferation marker in SGT by immunohistochemical analysis with 74.3% sensitivity and 93.3% specificity between malignant and benign SGT. 31 A recent study on the expression of SPAG9 has predicted presence of malignant endometrium with 74% sensitivity, 83% specificity, 88% PPV, and 64.5% NPV. 32 In our study, SPAG9 protein expression in IHC predicted presence of malignant SGT with 83.72% sensitivity, 100% specificity, 100% PPV, and 83.72% NPV.…”
Section: Discussionmentioning
confidence: 99%
“…They also suggest that MCM-3 expression is a more sensitive marker of proliferation than Ki-67 expression in case of salivary gland epithelial tumors, such as pleomorphic adenomas, mucoepidermoid carcinomas, and adenoid cystic carcinomas, in adults [24].…”
Section: Discussionmentioning
confidence: 98%
“…But most research mainly concentrated in the laboratory research (Tadbir et al, 2012;Ashkavandi et al, 2013;Jaafari et al, 2013), rarely used for guiding clinical therapy at present (Iqbal et al, 2014). Current views of clinical study for effect of ACC chemotherapy is not consistent, the choice of chemotherapy plan is difference.…”
Section: Discussionmentioning
confidence: 99%